Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global oral thin films market size was valued at USD 3.60 billion in 2023, driven by the increasing prevalence of neurological disorders across the globe. The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032 to achieve a value of USD 7.80 billion by 2032.
Oral thin films are polymers that are water soluble in nature. These polymer strips dissolve when comes in contact of saliva and takes only a few seconds. This technology has already been explored by confectionary market to manufacture mouth freshener strips. Pharmaceutical and healthcare industry is also emphasizing on exploring the potential of using it and manufacturing the drugs and medications for patients in similar category as well. The constituents of these films are water, components are held together by stabilizers, flavors, saliva stimulators, colorants and some more.
Oral thin films (OTFs) have gained significant attention and popularity in the pharmaceutical industry in past years. Oral thin films provide a convenient and patient-friendly alternative to traditional dosage forms like tablets or capsules. They are thin, portable, and do not require water for administration, making them easy to use, particularly for patients who have difficulty swallowing or dislike taking oral medications. The formulation of oral thin films is done to rapidly disintegrate or dissolve in the oral cavity, allowing for quick absorption of the medication. This can lead to a faster onset of action compared to traditional oral dosage forms. This makes them appropriate for medications that need instant relief or quick action.
There are several key trends running in the oral thin films market and some of them include the ongoing research studies on the development of oral thin films to contribute to the development of personalized drug delivery system. Increasing number of retailing pharmacies is also increasing the availability of the oral thin film products which is directly contributing to the global oral thin films market growth. Due to the ongoing research in the field of pharmaceutical industry on oral thin films, development of several different drugs to treat several other diseases and disorders is in process. With the use of active ingredients such as Montelukast, Insulin, Rizatriptan, and Testosterone, Pharmaceutical companies has been trying to develop treatment drugs in the form of oral thin films for dementia, diabetes, migraines, male hypogonadism respectively.
The increasing emphasis on sustainability and eco-consciousness, the pharmaceutical products are also experiencing the positive impact and it is resulting in increasing interest in sustainable packaging for them including oral thin films. Manufacturers are exploring environmentally friendly packaging materials and adopting eco-friendly practices, which align with the broader sustainability trends in the market.
Market Breakup by Products
Market Breakup by Disease Indication
Market Breakup by End User
Market Breakup by Region
The market is witnessing a significant growth and is expected to grow in coming years as well. There several factors driving the market growth includes the increasing prevalence of disability disorders and aging population. The development of oral thin films has been put to use so that aging people who have difficulty swallowing hard size pills and capsules find it convenient to consume their medications in the form of these oral thin films propelling the global oral thin films market growth.
Increasing availability due to the increase in number of retail pharmacies has also escalated growth of the product in the market. Increasing prevalence of neurological disorders has also increased the consumption of drugs and medicines in the form of oral thin films contributing to the growth of the market size.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Products |
|
Breakup by Disease Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 3.60 billion in 2023, driven by the prevalence of neurological disorders.
The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032, likely to reach a market value of USD 7.80 billion by 2032.
The increasing availability of oral thin films due to the increase in number of retail pharmacies in the market is among the major drivers for the market.
The ongoing research in the field of pharmaceutical industry to develop drugs for diseases like migraines, diabetes, dementia and more is one of the major trends among others in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products available in the market are sublingual films and some other products.
The end users in the market include hospital pharmacies, retail pharmacies, other distribution channels.
The indications in the market include blood cancer, solid tumours, among other indications.
Key players involved in the market are Aquestive Therapeutics Inc., LTS Lohmann Therapie-Systeme AG, IntelGenx Corp., C.L.Pharm, CURE Pharmaceutical, ZIM Laboratories Limited, Sunovion Pharmaceuticals Inc., and Viatris.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share